Predictive value of platelet-to-albumin ratio combined with the C
Humans
ST Elevation Myocardial Infarction
/ blood
Atrial Fibrillation
/ diagnosis
Male
Female
Aged
Percutaneous Coronary Intervention
/ adverse effects
Predictive Value of Tests
Risk Factors
Risk Assessment
Biomarkers
/ blood
Blood Platelets
/ metabolism
Treatment Outcome
Age Factors
Serum Albumin, Human
/ analysis
Aged, 80 and over
Platelet Count
Decision Support Techniques
Retrospective Studies
Middle Aged
Time Factors
Acute myocardial infarction
C2HEST score
Elderly
New-onset atrial fibrillation
Platelet to albumin ratio
Journal
BMC cardiovascular disorders
ISSN: 1471-2261
Titre abrégé: BMC Cardiovasc Disord
Pays: England
ID NLM: 100968539
Informations de publication
Date de publication:
27 Sep 2024
27 Sep 2024
Historique:
received:
18
07
2024
accepted:
17
09
2024
medline:
28
9
2024
pubmed:
28
9
2024
entrez:
28
9
2024
Statut:
epublish
Résumé
New-onset atrial fibrillation (NOAF) is a common adverse outcome in acute ST-segment elevation myocardial infarction (STEMI) patients following percutaneous coronary intervention (PCI) and is associated with a worse prognosis. The platelet-to-albumin ratio (PAR) has been utilized to predict the severity and prognosis of cardiovascular diseases. This study aims to investigate the predictive value of PAR combined with the C 445 elderly STEMI patients without a history of atrial fibrillation (AF) who underwent PCI were consecutively enrolled in this study. Multivariate logistic regression analysis was used to identify independent risk factors for NOAF after PCI. 50 patients (11.2%) developed NOAF after PCI. Multivariate logistic regression analysis revealed that heart rate (HR), systemic immune-inflammation index (SII), uric acid (UA), PAR, and C The combination of PAR and the C
Sections du résumé
BACKGROUND
BACKGROUND
New-onset atrial fibrillation (NOAF) is a common adverse outcome in acute ST-segment elevation myocardial infarction (STEMI) patients following percutaneous coronary intervention (PCI) and is associated with a worse prognosis. The platelet-to-albumin ratio (PAR) has been utilized to predict the severity and prognosis of cardiovascular diseases. This study aims to investigate the predictive value of PAR combined with the C
METHODS
METHODS
445 elderly STEMI patients without a history of atrial fibrillation (AF) who underwent PCI were consecutively enrolled in this study. Multivariate logistic regression analysis was used to identify independent risk factors for NOAF after PCI.
RESULTS
RESULTS
50 patients (11.2%) developed NOAF after PCI. Multivariate logistic regression analysis revealed that heart rate (HR), systemic immune-inflammation index (SII), uric acid (UA), PAR, and C
CONCLUSION
CONCLUSIONS
The combination of PAR and the C
Identifiants
pubmed: 39333846
doi: 10.1186/s12872-024-04200-7
pii: 10.1186/s12872-024-04200-7
doi:
Substances chimiques
Biomarkers
0
Serum Albumin, Human
ZIF514RVZR
ALB protein, human
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
521Informations de copyright
© 2024. The Author(s).
Références
Mazzone A, Scalese M, Paradossi U, Del Turco S, Botto N, De Caterina A, Trianni G, Ravani M, Rizza A, Molinaro S, et al. Development and validation of a risk stratification score for new-onset atrial fibrillation in STEMI patients undergoing primary percutaneous coronary intervention. Int J Clin Pract. 2018;72(4):e13087.
doi: 10.1111/ijcp.13087
pubmed: 29665154
Rene AG, Généreux P, Ezekowitz M, Kirtane AJ, Xu K, Mehran R, Brener SJ, Stone GW. Impact of atrial fibrillation in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention (from the HORIZONS-AMI [Harmonizing outcomes with revascularization and stents in Acute Myocardial Infarction] trial). Am J Cardiol. 2014;113(2):236–42.
doi: 10.1016/j.amjcard.2013.09.016
pubmed: 24176066
Morishima I, Tomomatsu T, Okumura K, Sone T, Tsuboi H, Morita Y, Inoue Y, Yoshida R, Yura Y, Murohara T. New-onset atrial fibrillation may be a more important predictor of cardiac mortality in acute myocardial infarction patients than preexisting atrial fibrillation. Int J Cardiol. 2015;187:475–7.
doi: 10.1016/j.ijcard.2015.03.379
pubmed: 25846657
Petersen JK, Butt JH, Yafasova A, Torp-Pedersen C, Sørensen R, Kruuse C, Vinding NE, Gundlund A, Køber L, Fosbøl EL, Østergaard L. Incidence of ischaemic stroke and mortality in patients with acute coronary syndrome and first-time detected atrial fibrillation: a nationwide study. Eur Heart J. 2021;42(44):4553–61.
doi: 10.1093/eurheartj/ehab575
pubmed: 34477838
Raczkowska-Golanko M, Raczak G, Gruchała M, Daniłowicz-Szymanowicz L. Comprehensive Use of Routine Clinical parameters to identify patients at risk of New-Onset Atrial Fibrillation in Acute myocardial infarction. J Clin Med. 2021;10(16).
Zeng RX, Chen MS, Lian BT, Liao PD, Zhang MZ. Left ventricular ejection fraction and left atrium diameter related to new-onset atrial fibrillation following acute myocardial infarction: a systematic review and meta-analysis. Oncotarget. 2017;8(46):81137–44.
doi: 10.18632/oncotarget.20821
pubmed: 29113373
pmcid: 5655268
Rencuzogullari I, Çağdaş M, Karakoyun S, Yesin M, Gürsoy MO, Artaç İ, İliş D, Efe SC, Tanboga IH. Propensity score matching analysis of the impact of Syntax score and syntax score II on new onset atrial fibrillation development in patients with ST segment elevation myocardial infarction. Ann Noninvasive Electrocardiol. 2018;23(2):e12504.
doi: 10.1111/anec.12504
pubmed: 28975725
Biccirè FG, Tanzilli G, Prati F, Sammartini E, Gelfusa M, Celeski M, Budassi S, Barillà F, Lip GYH, Pastori D. Prediction of new onset atrial fibrillation in patients with acute coronary syndrome undergoing percutaneous coronary intervention using the C
doi: 10.1016/j.ijcard.2023.05.023
pubmed: 37201612
Li YG, Bisson A, Bodin A, Herbert J, Grammatico-Guillon L, Joung B, Wang YT, Lip GYH, Fauchier L. C
doi: 10.1161/JAHA.119.012546
pubmed: 31234697
pmcid: 6662366
Li YG, Pastori D, Miyazawa K, Shahid F, Lip GYH. Identifying At-Risk patients for sustained Atrial High-Rate episodes using the C
doi: 10.1161/JAHA.120.017519
pubmed: 33666093
pmcid: 8174218
Crea F, Libby P. Acute Coronary syndromes: the Way Forward from mechanisms to Precision Treatment. Circulation. 2017;136(12):1155–66.
doi: 10.1161/CIRCULATIONAHA.117.029870
pubmed: 28923905
pmcid: 5679086
Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352(16):1685–95.
doi: 10.1056/NEJMra043430
pubmed: 15843671
Libby P. Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol. 2012;32(9):2045–51.
doi: 10.1161/ATVBAHA.108.179705
pubmed: 22895665
pmcid: 3422754
Holinstat M. Normal platelet function. Cancer Metastasis Rev. 2017;36(2):195–8.
doi: 10.1007/s10555-017-9677-x
pubmed: 28667366
pmcid: 5709181
Don BR, Kaysen G. Serum albumin: relationship to inflammation and nutrition. Semin Dial. 2004;17(6):432–7.
doi: 10.1111/j.0894-0959.2004.17603.x
pubmed: 15660573
Arques S. Human serum albumin in cardiovascular diseases. Eur J Intern Med. 2018;52:8–12.
doi: 10.1016/j.ejim.2018.04.014
pubmed: 29680174
Song PS, Ahn KT, Jeong JO, Jeon KH, Song YB, Gwon HC, Rha SW, Jeong MH, Seong IW. Association of baseline platelet count with all-cause mortality after acute myocardial infarction. Eur Heart J Acute Cardiovasc Care. 2021;10(2):176–83.
doi: 10.1177/2048872620925257
pubmed: 32403936
Tan J, Song G, Wang S, Dong L, Liu X, Jiang Z, Qin A, Tang Y, Qin W. Platelet-to-albumin ratio: a novel IgA. Nephrop Prognosis Predictor. 2022;13:842362.
Hao P, Feng S, Suo M, Wang S, Wu X. Platelet to albumin ratio: a risk factor related to prognosis in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention. Int J Cardiol. 2024;395:131588.
doi: 10.1016/j.ijcard.2023.131588
pubmed: 37989451
Saito N, Shirai Y, Horiuchi T, Sugano H, Shiba H, Sakamoto T, Uwagawa T, Yanaga K. Preoperative platelet to albumin ratio predicts outcome of patients with Cholangiocarcinoma. Anticancer Res. 2018;38(2):987–92.
pubmed: 29374731
Mrdovic I, Savic L, Krljanac G, Perunicic J, Asanin M, Lasica R, Antonijevic N, Kocev N, Marinkovic J, Vasiljevic Z, Ostojic M. Incidence, predictors, and 30-day outcomes of new-onset atrial fibrillation after primary percutaneous coronary intervention: insight into the RISK-PCI trial. Coron Artery Dis. 2012;23(1):1–8.
doi: 10.1097/MCA.0b013e32834df552
pubmed: 22107800
Reinstadler SJ, Stiermaier T, Eitel C, Fuernau G, Saad M, Pöss J, de Waha S, Mende M, Desch S, Metzler B, et al. Impact of Atrial Fibrillation during ST-Segment-Elevation myocardial infarction on infarct characteristics and prognosis. Circ Cardiovasc Imaging. 2018;11(2):e006955.
doi: 10.1161/CIRCIMAGING.117.006955
pubmed: 29391346
Clark DM, Plumb VJ, Epstein AE, Kay GN. Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation. J Am Coll Cardiol. 1997;30(4):1039–45.
doi: 10.1016/S0735-1097(97)00254-4
pubmed: 9316536
Sagris M, Vardas EP, Theofilis P, Antonopoulos AS, Oikonomou E, Tousoulis D. Atrial fibrillation: Pathogenesis, predisposing factors, and Genetics. Int J Mol Sci. 2021;23(1):6.
doi: 10.3390/ijms23010006
pubmed: 35008432
pmcid: 8744894
Hu YF, Chen YJ, Lin YJ, Chen SA. Inflammation and the pathogenesis of atrial fibrillation. Nat Rev Cardiol. 2015;12(4):230–43.
doi: 10.1038/nrcardio.2015.2
pubmed: 25622848
Li H, Meng S, Chen W, Lei X, Kong X, Zhu H. Comparison of different systemic inflammatory markers in Predicting Clinical outcomes with Syntax score in patients with Non-ST segment elevation myocardial infarction: a retrospective study. Int J Gen Med. 2023;16:2595–607.
doi: 10.2147/IJGM.S413538
pubmed: 37362824
pmcid: 10289247
Li W, Song Y. Red cell distribution width to albumin ratio is a risk factor for atrial fibrillation in subjects hospitalized with coronary angiography. BMC Cardiovasc Disord. 2024;24(1):95.
doi: 10.1186/s12872-024-03772-8
pubmed: 38331757
pmcid: 10854169
Huang YW, Yin XS, Li ZP. Association of the systemic immune-inflammation index (SII) and clinical outcomes in patients with stroke: a systematic review and meta-analysis. Front Immunol. 2022;13:1090305.
doi: 10.3389/fimmu.2022.1090305
pubmed: 36591305
pmcid: 9797819
Li J, Cao D, Huang Y, Xiong Q, Tan D, Liu L, Lin T, Wei Q. The prognostic and clinicopathological significance of systemic Immune-inflammation index in bladder Cancer. Front Immunol. 2022;13:865643.
doi: 10.3389/fimmu.2022.865643
pubmed: 35572533
pmcid: 9097688
Karakayali M, Altunova M, Yakisan T, Aslan S, Omar T, Artac I, Ilis D, Arslan A, Cagin Z, Karabag Y, Rencuzogullari I. The relationship between the systemic Immune-inflammation index and ischemia with non-obstructive coronary arteries in patients undergoing coronary angiography. Arq Bras Cardiol. 2024;121(2):e20230540.
doi: 10.36660/abc.20230540
pubmed: 38597536
Arques S. Serum albumin and cardiovascular disease: state-of-the-art review. Ann Cardiol Angeiol (Paris). 2020;69(4):192–200.
doi: 10.1016/j.ancard.2020.07.012
pubmed: 32797938
Huang Y, Deng W, Pan X, Liu M, Zhong Z, Huang Q, Li T. The relationship between platelet to albumin ratio and disease activity in axial spondyloarthritis patients. Mod Rheumatol. 2022;32(5):974–9.
doi: 10.1093/mr/roab060
pubmed: 34918121
Crowley SD. The cooperative roles of inflammation and oxidative stress in the pathogenesis of hypertension. Antioxid Redox Signal. 2014;20(1):102–20.
doi: 10.1089/ars.2013.5258
pubmed: 23472597
pmcid: 3880899
Medina-Leyte DJ, Zepeda-García O, Domínguez-Pérez M, González-Garrido A, Villarreal-Molina T, Jacobo-Albavera L. Endothelial dysfunction, inflammation and coronary artery disease: potential biomarkers and promising therapeutical approaches. Int J Mol Sci. 2021;22(8):3850.
doi: 10.3390/ijms22083850
pubmed: 33917744
pmcid: 8068178
Wrigley BJ, Lip GY, Shantsila E. The role of monocytes and inflammation in the pathophysiology of heart failure. Eur J Heart Fail. 2011;13(11):1161–71.
doi: 10.1093/eurjhf/hfr122
pubmed: 21952932